P659-1685 Screening compound: 4-{2-[(4-benzylpiperidin-1-yl)methyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}morpholine

P659-1685 Screening compound: 4-{2-[(4-benzylpiperidin-1-yl)methyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}morpholine
P659-1685 Screening compound: 4-{2-[(4-benzylpiperidin-1-yl)methyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound P659-1685
4-{2-[(4-benzylpiperidin-1-yl)methyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P659-1685

Molecular Formula

C23H30N6O (C23 H30 N6 O)

Compound Name

4-{2-[(4-benzylpiperidin-1-yl)methyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}morpholine

IUPAC name

4-{2-[(4-benzylpiperidin-1-yl)methyl]-5-methyl-[124]triazolo[15-a]pyrimidin-7-yl}morpholine

SMILES

Cc1nc2nc(CN3CCC(Cc4ccccc4)CC3)nn2c(N2CCOCC2)c1

InChI

InChI=1S/C23H30N6O/c1-18-15-22(28-11-13-30-14-12-28)29-23(24-18)25-21(26-29)17-27-9-7-20(8-10-27)16-19-5-3-2-4-6-19/h2-6,15,20H,7-14,16-17H2,1H3

InChI Key

RBRXWKRKQYTSIK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27609833

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

406.53

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.332

Distribution Coefficient, logD

3.031

Water Solubility, LogSw

-3.36

Polar Surface Area

45.749

Acid Dissociation Constant (pKa)

24.79

Base Dissociation Constant (pKb)

7.40

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.20

P659-1685 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
  • Proteases
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P659-1685 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P659-1685?
Check Price and Availability of P659-1685, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P659-1685 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P659-1685
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P659-1685
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P659-1685 available by request